Patents by Inventor Filip Boyen

Filip Boyen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine strains of brachyspira hyodysenteriae
    Patent number: 10821165
    Abstract: The present invention relates to Brachyspira hyodysenteriae strains and their use in diagnosis or treatment. In addition, the invention provides a vaccine against diarrheal disease, in particular swine dysentery.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: November 3, 2020
    Assignee: Universiteit Gent
    Inventors: Maxime Mahu, Frank Pasmans, Filip Boyen, An Martel, Freddy Haesebrouck, Sven Arnouts
  • VACCINE STRAINS OF BRACHYSPIRA HYODYSENTERIAE
    Publication number: 20190015495
    Abstract: The present invention relates to Brachyspira hyodysenteriae strains and their use in diagnosis or treatment. In addition, the invention provides a vaccine against diarrheal disease, in particular swine dysentery.
    Type: Application
    Filed: December 22, 2016
    Publication date: January 17, 2019
    Inventors: Maxime MAHU, Frank PASMANS, Filip BOYEN, An MARTEL, Freddy HAESEBROUCK, Sven ARNOUTS
  • vaccine
    Patent number: 9399057
    Abstract: The present invention relates to novel Salmonella mutants, to a process for producing same and to vaccines containing same, wherein said Salmonella mutants are characterized in that they elicit a humoral response that can be distinguished from the humoral response elicited by the wild type strains. It is accordingly an object of the present invention to provide the use of said Salmonella mutants as serological marker strains in the vaccination of animals, in particular mammals and birds, more in particular cattle, poultry and pigs. The serological marker vaccine is of special value in animal farming and provides a (long-lasting) immunization against a wide range of Salmonella strains. The novel mutants are non-reverting and can be used for the efficient immunization of mammals and birds.
    Type: Grant
    Filed: January 26, 2011
    Date of Patent: July 26, 2016
    Assignee: Universiteit Gent
    Inventors: Filip Boyen, Frank Pasmans, Freddy Haesebrouck
  • SALMONELLA VACCINE
    Publication number: 20130052230
    Abstract: The present invention relates to novel Salmonella mutants, to a process for producing same and to vaccines containing same, wherein said Salmonella mutants are characterized in that they elicit a humoral response that can be distinguished from the humoral response elicited by the wild type strains. It is accordingly an object of the present invention to provide the use of said Salmonella mutants as serological marker strains in the vaccination of animals, in particular mammals and birds, more in particular cattle, poultry and pigs. The serological marker vaccine is of special value in animal farming and provides a (long-lasting) immunization against a wide range of Salmonella strains. The novel mutants are non-reverting and can be used for the efficient immunization of mammals and birds.
    Type: Application
    Filed: January 26, 2011
    Publication date: February 28, 2013
    Applicant: UNIVERSITEIT GENT
    Inventors: Filip Boyen, Frank Pasmans, Freddy Haesebrouck